Phasex Corporation is the leading innovator in Supercritical Fluids and is frequently quoted and its activities followed in the trade literature. The articles listed highlight our pioneering efforts. This page will be continuously updated.
Current Articles | RSS Feed
LAVIPHARM LABORATORIES Inc. has acquired exclusive and perpetual rights to Phasex Corporation’s supercritical fluids (SCF) technology, patents, trademark and know-how for use in the pharmaceutical and cosmetics fields. Lavipharm has also acquired a 30 percent equity stake in Phasex, with the right to purchase the remainder of the company.
Lavipharm Laboratories is a particle and formulation design company with expertise in molecular transport. Located in East Windsor, N.J., it is the research and development arm of the Lavipharm Group.
The Phasex deal caps a busy autumn for Lavipharm. In October, Lavipharm announced plans to buy another SCF business, France-based Separex.
Allowed tags: <a> link, <b> bold, <i> italics
Ask us about our No Cost Test on YOUR product today!